CIN: U46497TN2026PTC189302 | 22 Years of Pharmaceutical Legacy | Madurai, Tamil Nadu, India
Providing targeted pharmaceutical formulations across 11 core clinical specialties.
High formulation standards
Transparent business ethics
Improving health accessibility
Dependable medical partnerships
Addressing high-prevalence acute and chronic conditions through rigorous quality control, modern drug molecules, and dependable clinical efficacy.
DPP-4 inhibitors, sulfonylureas, and dual metformin combinations for comprehensive Type 2 glycemic care.
Explore FormulationsBroad-spectrum macrolides, cephalosporins, and fluoroquinolone combinations for bacterial infections.
Explore FormulationsBalanced calcium channel blockers and beta blockers for consistent arterial pressure regulation.
Explore FormulationsMyocardial metabolic cytoprotective agents for chronic stable angina pectoris and cardiac endurance.
Explore FormulationsHigh-potency HMG-CoA reductase inhibitors for dyslipidemia and primary cardiovascular prevention.
Explore FormulationsSynergistic pregabalin and methylcobalamin formulations for nerve repair and neuropathic relief.
Explore FormulationsComplete micronutrient and essential mineral combinations to support immune defense and vitality.
Explore FormulationsHigh-bioavailability calcium formulations with Vitamin D3 for bone mineral density and strength.
Explore FormulationsTargeted analgesics, anti-pyretics, and anti-inflammatory enzyme complexes for acute pain and edema.
Explore FormulationsNon-sedating antihistamines and leukotriene receptor antagonists for allergic rhinitis and asthma.
Explore FormulationsAdvanced acid suppression formulations with prokinetic motility agents for GERD and peptic ulcers.
Explore Formulations
“Over their 22-year presence in the pharmaceutical sector, DCC has continually maintained remarkable consistency in product quality, therapeutic efficacy, and dependable ethical supply across acute and chronic patient care.”
“DCC Pharmaceuticals' anti-diabetic and cardiovascular portfolios demonstrate high formulation purity and bioavailability. Their dedicated focus on patient outcomes makes them a trusted partner in clinical practice.”
“As a distribution partner, our relationship with DCC Pharmaceuticals is built on ethics, prompt fulfilment, and professional integrity. The new corporate chapter under DCC Pharmaceuticals Private Limited marks an exciting horizon.”
Senior Physician
Consultant Diabetologist
Clinical Specialist
Cardiovascular Medicine
Regional Distributor
Healthcare Logistics Partner
DCC Pharmaceuticals Private Limited carries forward a 22-year legacy in pharmaceutical marketing, providing quality acute and chronic medical solutions across India.
CIN: U46497TN2026PTC189302 | Nature of Business: Pharmaceutical Marketing
© 2026 DCC Pharmaceuticals Private Limited. All Rights Reserved.